|
" Recombinant Antibodies for Cancer Therapy : "
Martin Welschof
Document Type
|
:
|
BL
|
Record Number
|
:
|
725275
|
Doc. No
|
:
|
b544994
|
Main Entry
|
:
|
Martin Welschof
|
Title & Author
|
:
|
Recombinant Antibodies for Cancer Therapy : : Reviews and Protocols.\ Martin Welschof
|
Publication Statement
|
:
|
Totowa: Humana Press, 2002
|
Series Statement
|
:
|
Methods in molecular biology Recombinant antibodies for cancer therapy
|
Page. NO
|
:
|
(497 pages).
|
ISBN
|
:
|
0896039188
|
|
:
|
: 1592593348
|
|
:
|
: 9780896039186
|
|
:
|
: 9781592593347
|
Contents
|
:
|
Recombinant Antibodies for Cancer Therapy"; "Preface"; "Contents"; "Contributors"; "INTRODUCTION"; "1 Generation of Antibody Molecules Through Antibody Engineering"; "2 Application of Recombinant Antibodies in Cancer Patients"; "HYBRIDOMA-DERIVED ANTIBODIES"; "3 DNA Immunization as a Means to Generate Antibodies to Proteins"; "4 Chimerization of a Monoclonal Antibody for Treating Hodgkin�s Lymphoma"; "5 Humanization of Monoclonal Antibodies by CDR Grafting"; "RECOMBINANT ANTIBODY FRAGMENTS FROM PHAGEMID-DISPLAYED ANTIBODY REPERTOIRES" "6 Generation and Screening of a Modular Human scFv Expression Library from Multiple Donors""7 Construction of Semisynthetic Antibody Libraries"; "8 Single-Domain VH Antibody Fragments from a Phage Display Library"; "9 Isolation of Human Fab Fragments Against Ovarian Carcinoma Using Guided Selection"; "10 Human Recombinant Fab Antibodies with T-Cell Receptor-Like Specificities Generated from Phage Display Libraries"; "11 Engineering Hot Spots for Affinity Enhancement of Antibodies"; "12 Simultaneous Humanization and Affinity Optimization of Monoclonal Antibodies" "13 Tailoring Kinetics of Antibodies Using Focused Combinatorial Libraries""ANTIBODY FRAGMENTS WITH ADDITIONAL PROPERTIES"; "14 Engineering scFvs for Improved Stability"; "15 Recombinant Single-Chain and Disulfide-Stabilized Fv Immunotoxins for Cancer Therapy"; "16 Generation of Recombinant Immunotoxins for Specific Targeting of Tumor-Related Peptides Presented by MHC Molecules"; "17 Construction and Characterization of RNase-Based Targeted Therapeutics"; "18 Bispecific Diabodies for Cancer Therapy" "19 Generation and Characterization of Bispecific Tandem Diabodies for Tumor Therapy""20 Generation of Recombinant Multimeric Antibody Fragments for Tumor Diagnosis and Therapy"; "21 Construction and Characterization of Minibodies for Imaging and Therapy of Colorectal Carcinomas"; "22 Generation, Expression, and Monitoring of Recombinant Immune Receptors for Use in Cellular Immunotherapy"; "23 Tailoring Natural Effector Functions Antibody Engineering Beyond Humanization"; "24 Single-Chain Fv-Based Affinity Purification of the Cellular Stress Protein gp96 for Vaccine Development" "25 Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments""LARGE SCALE PRODUCTION OF RECOMBINANT ANTIBODIES FOR CLINICAL APPLICATION"; "26 Production of Antibody Fragments in a Bioreactor"; "27 Large Scale Production of Recombinant Antibodies by Utilizing Cellulose-Binding Domains"; "28 Production of Tumor-Specific Antibodies in Tobacco"; "Index"
|
Subject
|
:
|
Cancer -- Immunotherapy -- Laboratory manuals.
|
Subject
|
:
|
Cancer -- Immunotherapy.
|
Subject
|
:
|
Recombinant antibodies.
|
Added Entry
|
:
|
Jurgen Krauss
|
|
:
|
Martin Welschof
|
| |